RFX5 in cancer: context-dependent molecular functions and emerging translational relevance - Takeaways - MDSpire

RFX5 in cancer: context-dependent molecular functions and emerging translational relevance

  • By

  • Li Zhang

  • Shanmei Du

  • Kui Liu

  • July 1, 2026

  • 0 min

Share

  • 1

    RFX5 is a context-dependent transcriptional integrator with implications for cancer immunotherapy and targeted therapy.

  • 2

    In hepatocellular carcinoma, RFX5 is amplified, promoting tumor growth through the YWHAQ–PI3K/Akt signaling pathway.

  • 3

    RFX5 enhances antigen presentation and CD8+ T-cell infiltration in immune-inflamed tumors, correlating with better clinical outcomes.

  • 4

    Altered RFX5 expression is linked to clinical prognosis and immune checkpoint blockade response in specific tumor types.

  • 5

    RFX5's predictive value as a biomarker remains unverified beyond established immune biomarkers and requires further investigation.

Original Source(s)

Related Content